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Objectives: We investigated associations between full Electronic Medical Record (EMR) system adoption and drug use in 
healthcare organizations (HCOs) to explore whether EMR system features such as electronic prescribing, medicines reconcilia-
tion, and decision support, might be related to drug use by using the relevant nation-wide data. Methods: The study design was 
cross-sectional. Survey data of the level of adoption of EMR systems were collected for the Organization for Economic Co-oper-
ation and Development benchmarking information and communication technologies (ICT) study between November 2013 and 
January 2014, in Korea. Survey respondents were hospital chief information officers and medical practitioners in primary care 
clinics. From the national health insurance administrative dataset, two outcomes, the rate of antibiotic prescription and poly-
pharmacy with ≥6 drugs, were extracted. Results: We found that full EMR adoption showed a 16.1% lower antibiotic drug pre-
scription than partial adoption including paper-based medical charts in the hospital only (p = 0.041). Between EMR adoption 
status and polypharmacy prescription, only those clinics which fully adopted EMR showed significant associations with higher 
polypharmacy prescriptions (36.9%, p = 0.001). Conclusions: The findings suggested that there might be some confounding ef-
fects present and sophisticated ICT may provide some benefits to the quality of care even with some mixed results. Although a 
negative relationship between full EMR system adoption and antibiotic drug use was only significant in hospitals, EMR system 
functions searching drugs or listing specific patients might facilitate antibiotic drug use reduction. Positive relationships between 
full EMR system adoption and polypharmacy rate in general hospitals and clinics, but not hospitals, require further research. 
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I. Introduction
Antibiotics are essential to help the immune system elimi-
nate certain pathogenic bacteria and a wide range of medica-
tions are currently used for medical care [1]. However, high 
antibiotic use is a serious problem because it causes an in-
crease in antibiotic resistant bacteria. Additionally, prescrib-
ing multiple medicines to patients known as ‘polypharmacy’ 
is a serious concern in medical care because of increased 
chances of drug–drug interactions and other adverse effects 
[2]. Therefore, many countries are interested in monitoring 
antibiotic use.
 Regarding antibiotics, the rate of antibiotic use varies con-
siderably depending on the type of medical care or the loca-
tion of the healthcare facilities. A study using sampled am-
bulatory care visits found that the rate of antibiotic use was 
12.6% in the United States (US) [3]. However, another study 
showed that the rate of antibiotic use was 44.5%–51.4% in 
emergency departments (ED) depending on the state in the 
US [4]. The annual prevalence rate of antibiotic use was 29% 
(29 users per 100 patients) in the United Kingdom, which 
was measured by dividing the number of patients prescribed 
an antibiotic by the total number of patients in every data-
base mid-year in 2009 [5].
 For polypharmacy, the World Health Organization defined 
it as the administration of many drugs at the same time or 
the administration of an excessive number of drugs [6]. 
Previous studies suggest different thresholds of the count of 
concurrent medication taken, e.g., 5 or more [7], 6 or more 
[8], or 10 or more medications [9]. Approximately 15% of 
adults ≥20 years were prescribed with 5 or more drugs si-
multaneously for 30 days in 2011–2012 in a study using the 
US National Health and Nutrition Examination Survey data 
[10]. A study conducted in England found that 22% of pa-
tients were dispensed with 5 or more drugs in 2010 [2].
 Various factors are affecting the use of antibiotics and poly-
pharmacy. Currently, providers’ behavioral and recipients’ 
clinical parameters have been accepted as the main factors 
affecting the rate of antibiotics use and polypharmacy [11-
13]. However, other potential factors have not been fully 
investigated, such as the relationship between Electronic 
Medical Record/Health Record (EMR/EHR, hereafter EMR) 
systems adoption and antibiotic use and polypharmacy, 
which is the subject of this study. 
 EMR systems are increasingly used in healthcare settings. 
The adoption rate of EMR systems in the US was approxi-
mately 85% in hospitals as of December 2015 [14]. Accord-
ing to the European Union, the reported adoption rates of 
EMR systems are 85% and 93% in hospitals and clinics, re-
spectively [15,16]. The EMR adoption rates, including those 
of health care organizations (HCOs) with partial implemen-
tations, were 96.3% and 95.7% in hospitals and clinics as of 
December 2013 in Korea [17].
 The main functions of the EMR systems are to document 
patient care electronically and provide this information at 
the point of care. Most EMR systems provide other functions 
such as computer-based order entry, decision support, and 
analytics. Advanced medication management functions are 
available for recommending specific drugs based on clinical 
indications and any known interactions as well as dispatch-
ing reminders and alerts to inform the care team of any 
changes in clinical parameters or evidence-based changes. 
EMR systems allow searching for patients on specific drugs 
or monitoring of possible drug–drug interactions [18,19]. 
Healthcare providers can retrieve prescriptions, as well as 
dispense and administer drugs using the EMR systems. 
Healthcare providers can also obtain automated recommen-
dations for drug choices and other important tasks such as 
medicine review and reconciliation, which ultimately lead 
to more appropriate drug use [20]. These functionalities 
and actionable information support healthcare providers in 
making critical decisions and in adhering to organizational 
procedures and processes [21], which in turn, may impact 
prescription quality. 
 Based on these findings, we formulated a hypothesis that 
full EMR system adoption would improve drug use by 
lowering antibiotic prescription and polypharmacy rates 
compared with other systems including paper-based medi-
cal charts. Full EMR system adoption means an electronic 
system that is used to store and manage for all patient health 
information based on the guide from the Organization for 
Economic Co-operation and Development (OECD) [22]. The 
institutional theory may explain the proposed hypothesis. 
The theory posits that technological innovations improve ef-
ficiency and performance, and the government implements 
regulations on these technologies such as their adoption 
and encourages or requires adherence to specific guidelines. 
Finally, these institutions or regulations affect organizations 
[23-26]. There are regulations, and rules regarding the use of 
EMR systems (e.g., healthcare information exchanges) [27]. 
This is because EMR systems improve the efficiency of vari-
ous aspects of medical care such as quality of care including 
rational drug use. Generally, a reduction in the use of anti-
biotics and polypharmacy is considered as quality care and 
recommended by governments. Thus, to examine whether 
full EMR systems are associated with lower antibiotic use 
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and polypharmacy rates would be meaningful. 
 A systematic literature review reported the impact of 
an EHR system on the quality of drug use and found that 
higher guideline adherence was observed when the EHR 
system was used compared to the control group that did not 
use it [28]. A study investigated whether quality standards 
for good diabetic care in practice were achieved in the EMR 
system adoption and paper-based practice settings. It found 
that diabetes care standards were significantly of higher 
quality in sites with EHR system adoption than paper-based 
sites [29]. Although there are some reports that EMR adop-
tion status was not associated with any quality of care mea-
sures [30,31], the overall evidence warrants more research 
into the effects of EMR system adoption.
 Very few studies have investigated the relationship between 
drug use (particularly, antibiotics and polypharmacy) and 
EMR system adoption status. Therefore, the objective of this 
study was to investigate how EMR system adoption levels are 
associated with the quality of drug prescription and utiliza-
tion of drugs in Korea. Our hypothesis was that HCOs with 
a high level of EHR adoption are associated with lower rates 
of antibiotic drug use and polypharmacy prescriptions than 
those with lower EHR adoption levels. Thus, these results 
can also inform policymakers on the effectiveness of health-
care information and communication technologies (ICT).
II. Methods
1. Study Design 
This study used a cross-sectional design and in conducting 
the survey, we asked whether each HCO had adopted a full 
or partial EMR system or was using paper-based medical 
charts. For simplicity in interpreting the study findings, we 
used a simple design to compare HCOs that had fully adopt-
ed the EMR system with those that had partial EMR systems 
or paper-based medical charts. 
 As the main independent variable in this study, we mea-
sured two levels of EMR system implementation: full EMR 
system versus others. We assumed full EMR system adop-
tion as one in which patients’ data were mainly stored and 
electronically whereas the ‘others’ were both partial EMR 
systems and paper-based medical charts. The partial EMR 
system was defined as one some patients’ records are stored 
and managed electronically and some are on paper [22]. 
2. Data Collection
The study used both a nationwide survey data and ad-
ministrative data from the Health Insurance Review and 
Assessment Service (HIRA) in Korea. HIRA is one of the 
government agencies running the national health insurance 
program that provides professional health insurance review 
and assessment services in Korea [32]. 
 For the main independent variable, that is, the level of 
adoption of EMR systems, we evaluated full or partial EMR 
systems or paper-based medical records. The data retrieved 
from the survey conducted for the OECD benchmarking 
ICT study, which is one of the numerous OECD initiatives 
[22,33]. The survey instrument was developed by the OECD 
benchmarking ICT team. In addition to the original instru-
ment, the HIRA added other questions for purposes such as 
business. There were 280 general hospitals, 1,371 hospitals, 
and 26,063 clinics as of September 1, 2013. As study subjects, 
all general hospitals were included while we randomly se-
lected 288 of the 1,371 hospitals and 905 of the 26,063 clinics 
with 5% and 3% sampling errors, respectively. The HIRA 
conducted the surveys following the methodological guide-
lines of the OECD from November 19, 2013 to January 10, 
2014. The respondents were chief information officers (CIO) 
in hospitals and primary care practitioners in ambulatory 
clinics. 
 For the survey method, the HIRA contracted a profes-
sional survey company with a nationwide survey network. 
The company hired interviewers and instructed them to visit 
clinics where the medical providers were asked to answer the 
questionnaires. The HIRA, Ministry of Health and Welfare, 
and the Korean Hospital Association indirectly supported 
this survey through official administrative letters and adver-
tisements in their networks. There were 266 respondents at 
the general hospitals with a 95% response rate, whereas the 
hospitals and clinics had 288 and 906 (response rate, 80.4% 
and 67.2%) respondents, respectively.
 Regarding the HIRA administrative data, we used data 
coming from the Drug Utilization Index-linked Autonomy 
Program (DUILAP), which monitors specific drug utiliza-
tion such as antibiotics, injectables, and polypharmacy. If the 
HIRA detects hospitals or clinics with concerning practices 
such a high percentage of antibiotic drug use, a warning no-
tice is issued. Thus, hospitals and clinics could autonomously 
maintain an appropriate level of antibiotic drug use. 
 Lastly, this study linked the survey data with HIRA admin-
istrative data and selected final study subjects that had both 
the survey and administrative information. The number 
of original study subjects of the OECD survey was slightly 
reduced. Furthermore, to determine the percentage of anti-
biotic prescription, 264 general hospitals, 244 hospitals, and 
732 clinics were included. For the percentage of polyphar-
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macy prescription analysis, 264 general hospitals, 258 hospi-
tals, and 839 clinics were included.
 The Institutional Review Board of HIRA approved this 
study (IRB No. 2017-029-001).
3. Outcome and Covariate Measures
This study hypothesized that the EMR systems would be 
related to the use of antibiotic drugs and polypharmacy. The 
study selected the available two main outcome variables: the 
rate of prescription of antibiotics for outpatients with upper 
acute respiratory tract infection and rate of polypharmacy 
prescription, which were descriptively defined as the per-
centage of antibiotic prescriptions and prescriptions with ≥6 
drugs, respectively in each HCO. The former was calculated 
by dividing the number of antibiotic prescriptions by the 
total number of prescriptions and the latter by dividing the 
number of prescriptions with ≥6 drugs by the total number 
of prescriptions in each HCO. Both indices were target-
ing for outpatients. Regarding the diagnosis codes for the 
patients with upper acute respiratory tract infection, HIRA 
had managed the index using the primary diagnosis code 
in which the codes of the Korean Standard Classification of 
Diseases (KCD) are from J00 to J06. This data was retrieved 
from HIRA data warehouse systems based on each HCO, 
and the average rate per quarter was calculated for 2 years 
from January 1, 2014 to December of 2015. This means that 
the rate was averaged for 8 quarters for 2 years.
 The measures were descriptively defined following the 
OECD guidelines. To control for other factors that might 
affect the main study results, we selected several covariates 
from the HIRA data warehouse system, which are presented 
in Table 1.
4. Statistical Analysis
The unit of analysis in this study was the HCO: general 
hospitals, hospitals, and clinics. Furthermore, this study dif-
ferentiated general hospitals from other hospitals because 
Korean Medical Service Act [34] sets forth different estab-
lishment requirements for general hospitals with >100 beds 
and at least a minimum of five medical specialties. This 
study excluded the tertiary hospitals from the analysis be-
cause they had unique features such as having the college of 
medicine, 27 specialized medical departments, and so on. 
Hospitals differ from clinics in that they should have more 
Table 1. Description of major variables and covariates including data source
Variable Measures Data sourcesa
Outcome variables
   Antibiotics Percentage (%) of antibiotic prescriptions per quarter (average for 2 years: 2014, 
2015)
1




   EMR adoption status Measured with full EMR system or partial (using paper charts and electronic 
chart or paper chart only) EMR systems
2
Covariates
   Location Measured with a special district (SD) and mega metro cities (MMC) or not. SD 
only included Seoul, and MMC included all mega-metropolitan cities with 
population of more than a million
3
   Number of physicians Number of physicians 2, 3
   Foundation Private versus public 3
   Affiliation Having any contracts with other hospitals or clinics for purchasing medical sup-
plies or patient referrals
2
   ICT staff or ICT department Number of staff of ICT (general hospitals); having ICT department (hospitals 
and clinics)
2
   Beds Number of beds (general hospitals, hospitals); having beds or not (clinics) 3
EMR: Electronic Medical Record, ICT: information and communication technology.
aData sources: “1” a program on the Health Insurance Review and Assessment Service (HIRA) drug use evaluation, “2” Organiza-
tion for Economic Co-operation and Development Benchmarking ICT study, and “3” HIRA’s administrative data.
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than 30 beds. 
 This study tabulated the HCO covariates as the main 
independent variable measured by types of EMR systems 
based on two outcome variables separately and conducted 
tests such as the chi-square test of independence and t-test 
of mean differences. For the main statistical analysis, which 
was the association of the main independent variables (EMR 
types) with two outcome variables (antibiotic use, polyphar-
macy prescriptions), we used a generalized linear model 
with the GENMOD procedure having the option of log and 
link functions in SAS program version 9.4. 
III. Results
Table 2 shows the general characteristics of general hospitals, 
hospitals, and clinics based on the types of EMR system ad-
opted. Antibiotic drug use rate was lower in the full adoption 
system than in the partial adoption system including paper-
based medical charts, and the difference was statistically 
significant in hospitals (p = 0.006). However, partial EMR 
Table 2. General characteristics of study subjects by type of healthcare organization 
Type Clinic characteristic












Total (antibiotics n = 264; polypharmacy n = 264) 193 71 - 193 71 -
SD and MMC (%) 41.9 35.2 0.321 41.9 35.2 0.321
Number of physicians 47.3 40.2 0.145 47.3 40.2 0.145
Private foundation (%) 26.9 19.7 0.229 26.9 19.7 0.229
Affiliated with other hospitals (%) 77.2 76.1 0.845 77.2 76.1 0.845
Number of staff in ICT department 5.2 3.9 0.087 5.2 3.9 0.087
Number of beds 427.0 387.1 0.160 427.0 387.1 0.160
Antibiotic drug use/quarter (%) 37.8 38.8 0.607 - - -
Polypharmacy prescription (%) - - - 16.1 16.2 0.926
Hospitals Total (antibiotics n = 244; polypharmacy n = 258) 160 84 - 172 86 -
SD and MMC (%) 51.3 38.1 0.050 49.4 40.7 0.186
Number of physicians 8.2 6.1 0.003 8.0 6.1 0.003
Private foundation (%) 76.3 78.6 0.682 72.1 76.7 0.424
Affiliated with other hospitals (%) 54.4 46.4 0.238 53.5 50.0 0.597
ICT department with beds (%) 41.9 20.2 0.001 43.6 19.8 <0.001
Number of beds 138.3 139.5 0.926 152.6 133.7 0.168
Antibiotic drug use/quarter (%) 37.6 47.0 0.006 - - -
Polypharmacy prescription (%) - - - 11.4 12.2 0.619
Clinicsa Total (antibiotics n = 732; polypharmacy n = 839) 510 222 - 588 251 -
SD and MMC (%) 47.1 54.5 0.064 48.6 55.0 0.093
Number of physicians 1.3 1.4 0.491 1.3 1.4 0.389
Private foundation (%) 98.2 96.9 0.238 98.5 97.2 0.222
Affiliated with other hospitals (%) 26.3 21.6 0.181 26.0 21.5 0.166
ICT department (%) 2.0 2.3 0.798 1.7 2.4 0.504
Having beds (%) 48.2 58.1 0.014 45.8 57.0 0.003
Antibiotic drug use/quarter (%) 42.7 43.9 0.606 - - -
Polypharmacy prescription (%) - - - 12.6 9.0 <0.001
EMR: Electronic Medical Record, SD: special district, MMC: mega metro cities, ICT: information and communication technology.
aMost of clinics are private in Korea. 
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and paper-based medical charts had a lower percentage of 
prescriptions with >6 in clinics (p < 0.001) than other HCOs. 
Regarding organizational covariates, hospitals with full EMR 
adoptions had more physicians (p = 0.003) and a higher per-
centage with an ICT department (p = 0.001) in both antibiot-
ics and polypharmacy. Clinics with beds were more likely to 
have a partial EMR and paper-charts, which was statistically 
significant in both antibiotics (p = 0.014) and polypharmacy 
(p = 0.003). 
 Association of full EMR system adoption with antibiotic 
drug use rate is described in Table 3, which shows the regres-
sion results after controlling for clinic covariates. All three 
groups of HCOs (general hospitals, hospitals, and clinics) 
with full EMR systems had lower rates of antibiotic drug use 
than those with partial EMR and paper-charts. However, 
the relationship was only statistically significant in hospital 
groups. Hospitals with full EMR systems had a 16.1% lower 
rate (exp(-0.176) = 0.839) of antibiotic drug use than that 
of the partial EMR and paper-chart groups (16.1%; 95% CI, 
0.7–29.1; p = 0.041).
 Table 4 shows the results of the regression analysis of the 
association of polypharmacy prescription with full EMR sys-
tem adoption after controlling for several HCO covariates. 
Unlike the proposed hypothesis, general hospitals and clinics 
with full EMR system had higher rates of the prescription of 
polypharmacy than those without full EMR. Especially, clin-
ics with full EMR systems had higher rates of prescription 
of polypharmacy than those with partial EMR and paper-
charts. Clinics with full EMR systems had a 36.9% higher 
rate (exp(0.314) = 1.369) of polypharmacy than HCOs with 
Table 3. Association of EMR system adoption with prescriptions of antibiotics
Variable






Coefficient p-value Coefficient p-value Coefficient p-value
SD and MMC (ref: no SD and MMC) –0.014 0.796 0.047 0.561 –0.001 0.997
Number of physicians –0.005 0.001 –0.020 0.020 0.002 0.960
Private foundation (ref: public) 0.076 0.242 –0.125 0.216 –0.023 0.918
Affiliation status (ref: no affiliation) 0.064 0.308 –0.106 0.187 –0.002 0.978
ICT staffs/departmenta (ref: no ICT department) –0.005 0.243 0.024 0.793 –0.134 0.555
Bedsb 0.001 0.030 0.001 0.408 0.039 0.536
Full EMR system adoption (ref: partial EMR and paper charts) –0.014 0.814 –0.176 0.041 –0.024 0.723
EMR: Electronic Medical Record, SD: special district, MMC: mega metro cities, ICT: information and communication technology.
aNumber of ICT staff in general hospitals; percentage (%) with ICT department in hospitals and clinics.
bNumber of beds in general hospitals, hospitals; whether beds were available or not for clinics (ref = no bed).
Table 4. Association of EMR system adoption with polypharmacy
Variable






Coefficient p-value Coefficient p-value Coefficient p-value
SD and MMC (ref: no SD and MMC) –0.063 0.174 –0.242 0.057 –0.087 0.302
Number of physicians –0.006 <0.001 –0.023 0.056 –0.036 0.373
Private foundation (ref: public) –0.058 0.293 –0.273 0.069 0.216 0.481
Affiliation status (ref: no affiliation) –0.054 0.313 –0.137 0.278 0.081 0.404
ICT staffs/departmenta (ref: no ICT department) –0.004 0.320 –0.005 0.970 0.196 0.522
Bedsb 0.001 <0.001 0.001 0.417 –0.132 0.119
Full EMR system adoption (ref: partial EMR and paper charts) 0.018 0.729 –0.012 0.930 0.314 0.001
EMR: Electronic Medical Record, SD: special district, MMC: mega metro cities, ICT: information and communication technology.
aNumber of ICT staff in general hospitals; percentage (%) with ICT department in hospitals and clinics.
bNumber of beds in general hospitals and hospitals; whether beds were available or not for clinics (ref = no bed).
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partial EMR and paper-charts (36.9%; 95% CI, 14.3–63.9; p 
= 0.001).
IV. Discussion
This study investigated the association of EMR system adop-
tion levels with antibiotics drug use and polypharmacy. EMR 
adoption status was measured in two types of systems: the 
full EMR system and the others. The drug use was measured 
as the rates of antibiotic prescription and polypharmacy pre-
scription with ≥6 drugs. Functions of EMR systems, such as 
searching or listing specific patients or drugs, enabled us to 
predict potential relationships between EMR system adop-
tion levels and quality of drug use, which is reduced use of 
antibiotics and polypharmacy.
 The study revealed a negative association between EMR 
status and the rate of antibiotic drug use in all three groups 
of HCOs; however, only the hospital results were statisti-
cally significant. This result supports the initial hypothesis 
of this study that various functions of the EMR system 
would diminish the use of antibiotics. Our study results 
agree with those of previous studies in which the quality of 
care increased as the EMR system adoption levels increased 
[28,29,35,36]. The prescription rate of antibiotics was ap-
proximately 40%, which was the same as that reported in a 
previous study conducted in the US [4]. This may be because 
the severity of patients’ conditions was almost similar where 
the former was in outpatients with upper acute respiratory 
tract infection and the latter were patients who visited the 
ED.
 Furthermore, in this study, we also expected an association 
between polypharmacy and the level of EMR system adop-
tion because EMR systems feature increased information 
processing of good practices related to the volume of drugs. 
Functions of EMR systems would provide previous and 
current information on patient drug use to doctors, which 
would diminish the volume of drugs prescribed. However, in 
contrast to our expectation, the initial hypothesis was only 
supported in hospitals, but the relationship was not statisti-
cally significant. Moreover, the full EMR system had higher 
rates of polypharmacy with ≥6 drugs the other systems did 
in general hospitals and clinics. Especially, the full EMR 
system had a statistically significantly higher rate of poly-
pharmacy in clinics than the partial EMR and paper-chart 
systems did. 
 To logically explain our polypharmacy study results, we 
applied one of the arguments of the contingency theory. Gal-
braith [25,37] argued that when organizations face the need 
for information processing, they should choose to either 
reduce their information processing requirement or increase 
the capacity to process information. Examples of the former 
and the latter are creating slack resources (e.g., lowering the 
objectives) and hiring more staff or adopting EMR systems. 
Thus, the rate of polypharmacy may increase as the level of 
EMR system adoption increases. Several empirical studies 
might support this argument, such as one showing that an 
EMR system with point-of-care reminders helped medical 
providers to choose combination drugs and these EMR sys-
tem functions saved cost by encouraging the use of cheaper 
combination drugs for patients [38]. According to a study 
that investigated the association of EMR system sophistica-
tion with preventive healthcare resources for women, order-
ing healthcare tests increased as the EMR systems became 
more sophisticated from minimal basic to full EMR systems 
[39]. For example, the breast examination rate of providers 
with no or minimal EMR system was 20.27% and 34.96%, 
respectively, whereas that of providers with a full EMR sys-
tem was 44.98% [39]. Thus, the polypharmacy analysis re-
sults in clinics might align with these previous study results. 
 Although some of the study results differed slightly from 
our initial expectations, it is worth noting that full EMR sys-
tems may not necessarily markedly improve health care lev-
els because the study results showed contrasting effects. For 
example, a study found that hospital EDs with full EMR sys-
tems had 22.4% lower length of stay than EDs with minimal 
or no EMR did [40]. Another observational study assessing 
physician-patient encounters before and after the implemen-
tation of an EMR system in an outpatient clinic found no 
difference in the number of laboratory tests ordered [41]. 
 Previous empirical studies show the negative relationship 
between EMR systems and the quality of drug use. Stand-
alone e-prescribing or those integrated with an EMR system 
were shown to significantly reduce adverse drug events 
compared to paper-based prescriptions, as determined by 
parameters such as dosing errors and inappropriate abbre-
viations [35]. Another study also investigated the associa-
tion between the level of EHR system implementation (EHR 
system adoption vs. paper-chart only) and conformity of 
diabetic care and found that the conformity of practice with 
EHR systems was modestly higher than that without EHR 
systems, for three of the seven qualities measured [36].
 This study has limitations including the fact that the main 
independent variable was from the survey data of the nation-
wide survey for the OECD bench-marking study. Further-
more, the records used were based on the memories of ICT 
department managers and, there might have been recalling 
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bias from the respondents; thus, future studies should use 
more objective measures of EMR system adoption by verify-
ing its installation. Second, the interpretation of the study 
results would be limited in Korea because the results may 
differ depending on the study environments. Therefore, we 
hope that there would be some international complementary 
investigations on this topic. Third, although antibiotic drug 
usages and polypharmacy prescriptions are related to the 
severity of patients and the number of diagnoses of patients, 
this study could not include those variables. This fact might 
result in mixed effects. We hope that further studies could 
control these confounding effects. Additionally, the adoption 
of EMR continued after the survey period and that adop-
tion status of HCOs was not captured during the outcome 
data period. Lastly, this study used a cross-sectional design, 
which has limitations in investigating some causal relation-
ship. Thus, longitudinal studies to further investigate the 
relationship between EMR systems and drug use would be 
expedient. The EHR system, when properly implemented, 
can improve the quality of healthcare by increasing time ef-
ficiency and guideline adherence and reducing medication 
errors and adverse drug events [28,29]. 
 To expand the knowledge of the unknown effects of EMR 
systems and compensate for the limitations of our present 
study, we suggest that further studies using different de-
signs are necessary to confirm whether the results would be 
similar using a different data source. In addition, it would 
be important to further identify the specific aspects of EMR 
systems that reduce or increase the quality and volume of 
medications. HIRA changed the evaluation system of an-
tibiotics use in July of 2016 [42], which may have an influ-
ence on changing the behavior of antibiotics prescription 
in HCOs. Therefore, future research is needed to examine 
whether this policy change would impact on the antibiotics 
prescription. 
 Although this study did not produce any generalizable 
study results between EMR system adoption level and drug 
use, we believe that more sophisticated EMR systems would 
facilitate the reduction of the number of medications pre-
scribed by healthcare providers. 
 In conclusion, this study investigated whether EMR system 
adoption status was associated with antibiotic drug use and 
the volume of drug use. There might be some confound-
ing effects which were not taken into consideration in this 
study. Even with some mixed results a significant negative 
relationship between full EMR system adoption and antibi-
otic drug use only in hospitals, EMR system functions such 
as searching drugs or listing specific patients might facilitate 
antibiotic drug use reduction. Positive relationships between 
full EMR system adoption and polypharmacy rate in general 
hospitals and clinics, but not hospitals, require further re-
search. This study suggests that sophisticated ICT may pro-
vide some benefits to the quality of care.
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